ICH Q1A: Stability Testing of New Drug Substances and Products

ICH Q1B: Stability Testing: Photostability Testing of New Drug Substances and Products

ICH Q1C: Stability Testing: Requirements for New Dosage Forms

ICH Q1D: Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products

ICH Q1E: Evaluation for Stability Data

ICH Q2: Validation of Analytical Procedures: Text and Methodology

ICH Q3A: Impurities in New Drug Substances

ICH Q3B: Impurities in New Drug Products

ICH Q6A : Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances

ICH Q7: GOOD MANUFACTURING PRACTICES GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS

ICH Q8 Pharmaceutical Development

ICH Q3C (R6) IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS

ICHQ3D (R1) GUIDELINE FOR ELEMENTAL IMPURITIES

ICH M7 (R1) ASSESSMENT AND CONTROL OF DNA REACTIVE (MUTAGENIC) IMPURITIES IN PHARMACEUTICALS TO LIMIT POTENTIAL CARCINOGENIC RISK